What is Thyme Care?
Thyme Care is at the forefront of oncology navigation, dedicated to improving the cancer experience for patients. By integrating personalized navigation with support from expert oncology teams, the company aims to enhance access, optimize outcomes, and increase the affordability of cancer treatment. Thyme Care provides 24/7 virtual support and collaborates with health plans, oncology groups, and primary care providers to ensure comprehensive and coordinated care. Their focus on transforming the member experience and proactively reducing healthcare costs positions them as a key innovator in the healthcare technology sector.
How much funding has Thyme Care raised?
Thyme Care has raised a total of $371M across 5 funding rounds:
Unspecified
$22M
Series B
$60M
Series C
$95M
Private Equity
$97M
Series D
$97M
Unspecified (2021): $22M with participation from Frist Cressey Ventures, Andreessen Horowitz, Casdin Capital, AlleyCorp companies, and Bessemer Venture Partners
Series B (2023): $60M led by AlleyCorp, Foresite Capital, Frist Cressey Ventures, Andreessen Horowitz, Casdin Capital, and Town Hall Ventures
Series C (2024): $95M supported by Concord Health Partners, Andreessen Horowitz, and Frist Cressey Ventures
Private Equity (2025): $97M, investors not publicly disclosed
Series D (2025): $97M backed by JPMorgan Chase, Andreessen Horowitz, AlleyCorp companies, Texas Oncology, Concord Health Partners, Humana, Town Hall Ventures, Memorial Hermann Health Plan, CVS Health, Frist Cressey Ventures, and Foresite Capital
Key Investors in Thyme Care
Andreessen Horowitz
Founded in 2009, Andreessen Horowitz is a prominent venture capital firm that invests in both early-stage and growth-stage companies, known for its significant backing of technology and healthcare innovators.
Frist Cressey Ventures
Frist Cressey Ventures is a venture capital firm focused on accelerating the growth of innovative healthcare companies, providing capital and strategic support to transform healthcare delivery and improve patient outcomes.
Concord Health Partners
Concord Health Partners is an investment firm that focuses on mergers and acquisitions within the healthcare sector, aiming to combine businesses to drive innovation and efficiency in healthcare services.
What's next for Thyme Care?
With substantial new capital, Thyme Care is strategically positioned for significant expansion and further innovation in oncology navigation. The recent major strategic investment signals strong investor confidence in the company's model and its potential to disrupt traditional cancer care pathways. This funding will likely fuel advancements in their technology platform, broaden their reach to more patients and partners, and deepen their clinical support capabilities. Thyme Care's trajectory suggests a continued focus on improving patient outcomes and driving efficiency within the complex landscape of cancer treatment.
See full Thyme Care company page
